CytoReason Email Format
Biotechnology ResearchTel Aviv, Israel51-200 Employees
CytoReason is a biotechnology research company based in Tel Aviv, Israel that applies artificial intelligence to improve decision-making in drug development. It maintains an extensive database of public and proprietary data to map human diseases at tissue- and cell-level detail. The platform supports researchers across the drug development lifecycle by helping them identify targets, prioritize indications, and stratify patient populations, while program leaders can compare drugs across diseases or within a single disease and executives gain tools to manage portfolios. CytoReason operates in the biotechnology research space, serving biopharma scientists, program leaders, and executives who rely on data-driven insights to advance candidate therapies. In 2026, the company announced an AI chat-style assistant for pharmaceutical R&D during the JPM HealthCare Conference, reflecting an expansion of its practical tools for research teams.